Protease inhibitors protect growth factor activity in chronic wounds
- 1 October 1997
- journal article
- Published by Wiley in British Journal of Dermatology
- Vol. 137 (4) , 646-663
- https://doi.org/10.1111/j.1365-2133.1997.tb03804.x
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- α1-Antitrypsin Is Degraded and Non-Functional in Chronic Wounds But Intact and Functional in Acute Wounds: The Inhibitor Protects Fibronectin from Degradation by Chronic Wound Fluid EnzymesJournal of Investigative Dermatology, 1995
- Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds.Journal of Clinical Investigation, 1995
- Workshop on the Pathogenesis of Chronic WoundsJournal of Investigative Dermatology, 1994
- Wound therapy: growth factors as agents to promote healingTrends in Biotechnology, 1993